DR. VALERI GOUTSOULIAK, MD

Plain English
This study looked at patients diagnosed with anaplastic thyroid cancer in British Columbia from 1985 to 1999, involving 75 patients in total. They found that only 5% of the patients survived for five years after diagnosis, with those who received higher doses of radiotherapy (40 Gy or more) surviving longer—an average of 9 months compared to 3 months for others. This research highlights the importance of aggressive treatment options and suggests that patients who undergo surgery followed by high-dose radiotherapy may have better outcomes. Who this helps: This helps patients with anaplastic thyroid cancer and their doctors by providing insights into treatment options.

Plain English
This study looked at how two types of blockers (losartan and PD123319) affected a certain signal in heart cells from chick embryos when they were exposed to a substance called angiotensin II. The researchers found that losartan blocked 71% of the signal increase, while PD123319 blocked 40%. Together, both blockers stopped the signal entirely, showing that using both types might be necessary to fully counteract angiotensin II’s effects on heart cells. Who this helps: This research benefits doctors working to treat heart conditions related to angiotensin II.

Plain English
This study looked at how muscarinic receptors, which are critical for heart function, are arranged on heart cells from chick embryos and how they affect a specific chemical process called phosphatidylcholine hydrolysis. The researchers found that each heart cell had an average of about 84 clusters of these receptors, located mostly at the edges of the cells. When they stimulated the receptors with a substance called carbachol, the cells showed a significant increase in free choline and a decrease in certain cellular fats, indicating that the receptors play an important role in heart cell signaling. Who this helps: This benefits researchers and doctors working in cardiovascular health and could lead to better treatments for heart conditions.

Plain English
This study looked at how a hormone called angiotensin II (Ang II) affects heart cells (cardiomyocytes) from young chicks, specifically focusing on a protein called phosphatidylinositol 3-kinase (PI3K). The researchers found that Ang II significantly boosted the activity of PI3K, increasing its activity by 4.5 times in just one minute, and this led to more protein being produced by the heart cells. This is important because understanding how Ang II stimulates protein production could help us learn more about heart enlargement and related diseases. Who this helps: This research benefits doctors and researchers working on treatments for heart conditions.

Plain English
This study looked at how a hormone called angiotensin II affects heart cells, specifically how it helps generate certain signaling molecules known as inositol phosphates. The researchers found that when angiotensin II was added to heart cells, it significantly increased levels of these signaling molecules in just one minute. They also discovered that blocking a specific type of enzyme called tyrosine kinase reduced this effect, showing that tyrosine kinase plays a critical role in this process. Who this helps: This research benefits doctors and scientists working on heart-related conditions, as it gives insights into how heart cell signaling can be managed.

Plain English
This study looked at the hearts of two types of rats to understand how protein changes relate to heart growth, specifically focusing on a protein that weighs 120 kDa. They found that rats predisposed to heart enlargement (Dahl S rats) had more of this protein in their hearts when stimulated with a hormone called angiotensin II, especially when on a low salt diet, while normal rats (Dahl R rats) had less of it overall. This finding shows a clear link between heart enlargement and the amount of this specific protein, which might help us understand how to target heart conditions more effectively. Who this helps: This helps doctors and researchers working on treatments for heart disease.